• Thought Leader Series: The future of cancer and medical research, Emeritus Professor Ian Frazer

  • Nov 8 2022
  • Duración: 30 m
  • Podcast

Thought Leader Series: The future of cancer and medical research, Emeritus Professor Ian Frazer Por arte de portada

Thought Leader Series: The future of cancer and medical research, Emeritus Professor Ian Frazer

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • Emeritus Professor Ian Frazer
    University of Queensland

    The future of cancer and medical research

    In this episode, RCA Chief Executive Richard Vines speaks to Professor Ian Frazer about:

    • Inventing the technology behind the world’s first cancer vaccine
    • Vaccine hesitancy, and the potential of other vaccines for cancer
    • What makes the Translational Research Institute so special
    • The interface between clinicians, scientists and patients in medical research
    • Our expanding understanding of cancer and targeted treatment
    • The experience of being Australian of The Year, and what he’s working on now
    • How the Medical Research Future Fund works
    • The alleged brain drain of medical researchers from Australia
    • The need to better embed medical research into the health system
    • How he sees medical research benefiting patients in 10 years’ time
    More about Emeritus Professor Ian Frazer

    Ian and his colleague co-invented the technology behind the world’s first cervical cancer vaccine.

    He is the founding CEO of the Translational Research Institute in Brisbane, heads a biotechnology company working on new vaccine technologies, and chairs the advisory board of the Medical Research Future Fund.
    Más Menos
activate_primeday_promo_in_buybox_DT
Más Menos

Lo que los oyentes dicen sobre Thought Leader Series: The future of cancer and medical research, Emeritus Professor Ian Frazer

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles